Key takeaways:

Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers.

The system pairs with a retinal camera to detect more than mild diabetic retinopathy.

Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic partnership between AEYE Health and Ford Medical, according to a press release from AEYE.

The AI-driven technology, called AEYE-DS, works with compatible retinal cameras to enable point-of-care diabetic retinopathy screening. The partnership will see Ford Medical distribute the system to pharmacies and non-acute centers in the U.S., according to the release.

Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic partnership between AE

See Full Page